Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by MindMed
MindMed to Participate at May Investor Conferences
May 09, 2024
From
MindMed
Via
Business Wire
Tickers
MNMD
MindMed Reports First Quarter 2024 Financial Results and Business Updates
May 08, 2024
From
MindMed
Via
Business Wire
Tickers
MNMD
MindMed Presents Phase 2b Study of MM120 for Generalized Anxiety Disorder (GAD) at American Psychiatric Association (APA) Annual Meeting in New York
May 04, 2024
From
MindMed
Via
Business Wire
Tickers
MNMD
MindMed to Host Conference Call and Webcast to Discuss First Quarter 2024 Financial Results and Provide Business Update
May 02, 2024
From
MindMed
Via
Business Wire
Tickers
MNMD
MindMed to Present at Upcoming May Medical Conferences
April 25, 2024
From
MindMed
Via
Business Wire
Tickers
MNMD
MindMed Announces Voluntary Delisting from Cboe Canada
April 01, 2024
From
MindMed
Via
Business Wire
Tickers
MNMD
MindMed to Participate in the Leerink Partners 2024 Global Biopharma Conference
March 11, 2024
From
MindMed
Via
Business Wire
Tickers
MNMD
MindMed to Host Conference Call and Webcast to Discuss Data Update for MM120
March 01, 2024
From
MindMed
Via
Business Wire
Tickers
MNMD
MindMed Reports 2023 Financial Results and Business Updates
February 28, 2024
From
MindMed
Via
Business Wire
Tickers
MNMD
MindMed to Host Conference Call and Webcast to Discuss 2023 Financial Results and Provide Business Update
February 22, 2024
From
MindMed
Via
Business Wire
Tickers
MNMD
MindMed to Participate in the 34th Annual Oppenheimer Healthcare Life Sciences Conference
February 07, 2024
From
MindMed
Via
Business Wire
Tickers
MNMD
MindMed to Participate in the TD Cowen 3rd Annual Novel Mechanisms in Neuropsychiatry Summit
September 14, 2023
From
MindMed
Via
Business Wire
Tickers
MNMD
MindMed Reports Second Quarter 2023 Financial Results and Business Highlights
August 03, 2023
From
MindMed
Via
Business Wire
Tickers
MNMD
MindMed Urges Shareholders to Vote TODAY for Company Nominees Ahead of June 13th Deadline
June 09, 2023
From
MindMed
Via
Business Wire
Tickers
MNMD
Leading Proxy Advisory Firm ISS Recommends MindMed Shareholders Vote FOR All Six Company Nominees
June 05, 2023
From
MindMed
Via
Business Wire
Tickers
MNMD
MindMed to Present Data on the Preclinical Activity of MM-402 at the American Society of Clinical Psychopharmacology (ASCP) 2023 Annual Meeting
May 24, 2023
From
MindMed
Via
Business Wire
Tickers
MNMD
MindMed Announces Enrollment Milestone in Phase 2b Trial of MM-120 in Generalized Anxiety Disorder (GAD)
May 17, 2023
From
MindMed
Via
Business Wire
Tickers
MNMD
MindMed Reports First Quarter 2023 Financial Results and Business Highlights
May 04, 2023
From
MindMed
Via
Business Wire
Tickers
MNMD
MindMed Sends Letter to Shareholders Highlighting Company’s Positive Momentum and Value-Enhancing Strategy
May 02, 2023
From
MindMed
Via
Business Wire
Tickers
MNMD
MindMed to Participate in May Investor Conferences
April 26, 2023
From
MindMed
Via
Business Wire
Tickers
MNMD
MindMed Files Preliminary Proxy Statement for 2023 Annual Meeting
April 18, 2023
From
MindMed
Via
Business Wire
Tickers
MNMD
MindMed Collaborators Announce Positive Topline Data from Phase 2 Trial of Lysergide (LSD) in Major Depressive Disorder (MDD)
April 14, 2023
From
MindMed
Via
Business Wire
Tickers
MNMD
MindMed Appoints Mark R. Sullivan as Chief Legal Officer and Corporate Secretary
April 13, 2023
From
MindMed
Via
Business Wire
Tickers
MNMD
MindMed Reports Full Year 2022 Financial Results and Business Highlights
March 09, 2023
From
MindMed
Via
Business Wire
Tickers
MNMD
MindMed to Participate in March Investor Conferences
February 28, 2023
From
MindMed
Via
Business Wire
Tickers
MNMD
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
